Welcome Panthers Fans!

Check Out The All NEW & Original Carolina Panthers Den Message Board! - Many New Improvements & Features For Everyone! - New Photo Gallery Added!.... Please Register To Participate On The Forums Today! .... Updated 2007 Panthers Schedule Posted In Our Forums! .... Join Us For All The LATEST News & Discussions On Your Carolina Panthers Everyday!: Keyshawn Johnson Cut by Panthers!-Discuss on our Message Board NOW! .... Download Our NEW Panthers Den Toolbar And Get Panthers News Sent To Your Desktop! ..... Plenty Of Fun & Games: Enter Our Arcade Tournaments And Compete Against Other Forum Members! ....Try Our New Sports Bookie & Casino And Rack Up Your 'Gold Points!' .....Login To See Who Our Newest Member Of The Month Is And Find Out How YOU Can Be Our Next WINNER!!! .... We Have Something For Everyone! - Don't Miss Out On All The "Crazy Feline Fun!" At Carolina Panthers Den! - The Most "Interactive" Panthers Fansite & Message Board On The Net!!! - GUARANTEED!!!


Often Imitated, Never Duplicated!

Chances are….if you saw it somewhere else….it happened here first!

The #1 and only ‘originalCarolina Panthers Message Board & Fan-site!

Providing the most interactive & user friendly atmosphere for Panthers fans everywhere since 2004! From the latest Carolina Panthers news to exciting games, activities & fun, Carolina Panthers Den is the place to be! New Members are always welcomed!

Join us for discussions on the Carolina Panthers Today!

Please register an account or login to our Fan Forums by clicking the link below:

Carolina Panthers Message Board

The Friendliest & Best Interactive Carolina Panthers Community On The Net!

We offer more free features, games and originality for your entertainment enjoyment than you will find anywhere else!


Remembering Sam Mills #51 – 1959-2005

Gone But NEVER Forgotten!

Our Inspirational Leader-Always In Our Hearts!


Please Visit These Carolina Panthers Den Sponsors:

Vote For Carolina Panthers Den At These Sponsors Below. We Appreciate Your Support!


All material on this website may not be copied, distributed, and/or used without the expressed written permission of the Webmaster. The Panthers Den ® name and all versions contained herein, are trademarks of the Carolina Panthers Den Website & Forums, which is not affiliated in any way with the Carolina Panthers Franchise. The Carolina Panthers name and team logos are registered trademarks of the Carolina Panthers.
This site and any pages within are in no way affiliated with the National Football League. Content & Images displayed on this site are used under the fair use provision of the Copyright Act for purposes of comment, criticism, and news reporting.

Website Design & Images
Copyright © 2012 Carolina Panthers Den. All rights reserved.
Revised: 7/6/12.

Boys much more likely to grow out of asthma According to experts in the U.

The analysis is likely to encourage further study into the processes mixed up in advancement of asthma and the feasible explanations why gender difference may impact its prognosis. The experts figured asthma is more serious in postpubertal females than postpubertal men men with asthma and claim that hormonal mechanisms may play a role. Experts agree and state sex hormones might are likely involved in the symptoms of asthma and its own intensity and that the study points to an unidentified mechanism behind the advancement of asthma. The analysis was funded by the National Heart, Blood and Lung Institute, the overall Clinical Research Middle, and the National Middle for Research Assets. The study was released in the peer-examined medical journal: American Journal of Respiratory and Important Care Medicine.. Continue reading

Only a part of approved medicines is ever tested in pediatric clinical trials cafergot tablets price.

By Monica Heger Although kids suffer from many of the same diseases as adults and so are frequently treated with the same drugs, only a part of approved medicines is ever tested in pediatric clinical trials. To encourage more safety and efficacy studies of drugs in children, in 1997 the US Food and Medication Administration produced a special provision that grants six-month patent extensions to medicines screened in kids cafergot tablets price http://cafergot.net/cafergot-online.html . Dubbed the Pediatric Exclusivity Provision, the licensing position has led to more than 150 drugs now being qualified for specific make use of in children. Continue reading

In the prestigious journal Cell.

In the prestigious journal Cell, the Alzheimer's professional Bart De Strooper argues these studies are not pointless, but merely indicate what the next steps should be for the Alzheimer's research. This article – or rather, this message – will be pass on at the largest Neuroscience meeting that will take place mid-November in Washington. Bart De Strooper: We need to learn from AIDS, cholesterol or cancer analysis: we are able to only find a drug to treat Alzheimer's disease if we are willing to learn from the difficulties that we encounter tadalafil tablets 20mg http://tadora.biz/tadalafil-use.html . Continue reading

Johns Hopkins Kimmel Cancer Center scientists report.

30, 1993, and Feb. 28, 2005. The experts compared the survival of 345 of the individuals who had only surgery with 271 who were then treated with 5-fluorouracil -based chemotherapy agents and modern types of radiation. Patients receiving the mixed chemotherapy and radiation experienced an improved median survival in comparison to patients who didn’t . Two-yr survival also improved , as did five-year survival . Results will end up being published in the July 20 issue of the Journal of Clinical Oncology. The take-house message of this study is that sufferers who received combined chemotherapy and radiation seemed to have better survival than individuals who have surgery only, suggesting that it’s safe and beneficial if it’s done thoroughly and correctly, says Herman, assistant professor in the Department of Radiation Molecular and Oncology Radiation Sciences. Continue reading

Today led by a Virginia Commonwealth University researcher according to a report released.

The drug was effective among the subgroups of perimenopausal females as well as those who were postmenopausal. At that time the study started, the federal Meals and Drug Administration hadn’t yet approved Pristiq, which patients now typically take in 50 mg daily doses to treat depression. Kornstein said she actually is going to start recruiting individuals for a fresh, similar research using the 50 mg daily dose. Pristiq works by increasing the levels of norepinephrine and serotonin, natural chemicals in the mind that help keep mental balance. It really is manufactured by Pfizer and was authorized in 2008 to take care of depression among adults. Wyeth, a subsidiary of Pfizer today, supported the study financially. Cheap and effective treatment for malaria with one medication is no longer an option for most countries in Africa due to the speedy emergence of drug resistance. Continue reading

Announced today that it donated a lot more than 300.

Mirmira citing Beta-Pro LLC as a supply for human being islets and desire him the very best of good luck in his future research of diabetes at the IU College of Medication. Dr. Beta-Pro isolates and distributes insulin-making islet cells from surplus organs not really placed for entire organ transplant in GMP and GLP services. Beta-Pro then costs and recovers costs for the expenses for organ procurement, processing, preservation, quality control, storage space, managing, and delivery of islets, various other biomaterials, and biological data. Continue reading

Bayer Acquires Two Prescription Dermatology PRODUCTS from SkinMedica in the U.

Bayer Acquires Two Prescription Dermatology PRODUCTS from SkinMedica in the U suhagra cost http://suhagra100mg.net/suhagra-online.html .S. Intendis GmbH, which is component of Bayer Health care, has signed an contract to obtain two prescription dermatology products from SkinMedica, Inc., a dermatology company located in Carlsbad, CA, USA.S. By SkinMedica, Inc. Beneath the transaction, which is at the mercy of the required regulatory approvals still, Intendis shall acquire all commercial rights, including assigned agreements and intellectual property linked to the two products. The deal is likely to close in nov 2009. ‘We are seeing solid development of our existing portfolio of prescription dermatologicals in the U.S. Continue reading

Regarded as a miracle drug by some.

Anesthesia & Analgesia AVAILABLE THESE DAYS on the iPad Anesthesia & Analgesia for the iPad uses optimized digital technology to supply a print-like reading encounter. Navigation is definitely fast and intuitive, allowing visitors to easily switch between scanning quickly and reading in depth. The app was developed by and is being written by the IARS’s publishing partner, Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. We’re delighted to partner with International Anesthesia Research Society to bring the journal app for the iPad to associates offering a dynamic, integrated encounter with this content, added Karen Abramson, CEO and President of Wolters Kluwer Wellness Medical Research. Continue reading

Programmer of the VAP Cholesterol Check.

Mullen stated the patent must have a positive effect on his company’s business. We be prepared to see a rise in orders for our VAP Test due to the clinically validated capability to accurately statement apoB and since it is quickly getting more of a typical in determining cardiovascular disease risk in cholesterol tests. The VAP Check is available protected and nationwide by most insurance agencies, including Medicaid and Medicare. For more information contact 877.901.8510 or visit.. Atherotech receives patent for ApoB measurement for determining cardiovascular disease risk Atherotech, Inc., programmer of the VAP Cholesterol Check, has announced it provides received a patent on its solution to derive and statement apolipoprotein B100 utilizing the Vertical Car Profile technology. Continue reading

Now the BU group have continuing this strand of research.

Now the BU group have continuing this strand of research, utilising a number of statistical techniques to be able to provide educated commentary about the controversy of using prosthetics – and whether people that have prosthetic lower limbs working against sports athletes with no prosthetics are in an unfair benefit. The analysis analyses the outcomes of the men's running occasions performed in the London 2012 Paralympics Games by 3 different classifications of athlete with an amputation. Continue reading